Under is Validea’s guru elementary report for REPLIGEN CORP (RGEN). Of the 22 guru methods we observe, RGEN charges highest utilizing our Low PE Investor mannequin primarily based on the printed technique of John Neff. This technique seems for corporations with persistent earnings progress that commerce at a reduction relative to their earnings progress and dividend yield.
REPLIGEN CORP (RGEN) is a mid-cap progress inventory within the Biotechnology & Medication trade. The score utilizing this technique is 60% primarily based on the agency’s underlying fundamentals and the inventory’s valuation. A rating of 80% or above sometimes signifies that the technique has some curiosity within the inventory and a rating above 90% sometimes signifies robust curiosity.
The next desk summarizes whether or not the inventory meets every of this technique’s assessments. Not all standards within the beneath desk obtain equal weighting or are unbiased, however the desk gives a quick overview of the robust and weak factors of the safety within the context of the technique’s standards.
| P/E RATIO: | FAIL |
| EPS GROWTH: | PASS |
| FUTURE EPS GROWTH: | PASS |
| SALES GROWTH: | PASS |
| TOTAL RETURN/PE: | FAIL |
| FREE CASH FLOW: | PASS |
| EPS PERSISTENCE: | FAIL |
Detailed Evaluation of REPLIGEN CORP
Extra Info on John Neff
About John Neff: Whereas generally known as the supervisor with whom many high managers entrusted their very own cash, Neff was removed from the smooth-talking, high-profile Wall Streeter you may count on. He was mild-mannered and low-key, and the identical is perhaps stated of the Windsor Fund that he managed for greater than three many years. In truth, Neff himself described the fund as “comparatively prosaic, boring, [and] conservative.” There was nothing boring about his outcomes, nevertheless. From 1964 to 1995, Neff guided Windsor to a 13.7 % common annual return, simply outpacing the S&P 500’s 10.6 % return throughout that point. That 3.1 share level distinction is large over time — a $10,000 funding in Windsor (with dividends reinvested) at the beginning of Neff’s tenure would have ended up as greater than $564,000 by the point he retired, greater than twice what the identical funding within the S&P would have yielded (about $233,000). Contemplating the size of his tenure, that monitor report could also be one of the best ever for a supervisor of such a big fund.
Further Analysis Hyperlinks
About Validea: Validea is aninvestment researchservice that follows the printed methods of funding legends. Validea gives each inventory evaluation and mannequin portfolios primarily based on gurus who’ve outperformed the market over the long-term, together with Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For extra details about Validea, click here
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
